A CeeNU, CCNU, Lomustine CEP of the European Pharmacopoeia monograph is often referred to as a CeeNU, CCNU, Lomustine Certificate of Suitability (COS). The purpose of a CeeNU, CCNU, Lomustine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CeeNU, CCNU, Lomustine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CeeNU, CCNU, Lomustine to their clients by showing that a CeeNU, CCNU, Lomustine CEP has been issued for it. The manufacturer submits a CeeNU, CCNU, Lomustine CEP (COS) as part of the market authorization procedure, and it takes on the role of a CeeNU, CCNU, Lomustine CEP holder for the record. Additionally, the data presented in the CeeNU, CCNU, Lomustine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CeeNU, CCNU, Lomustine DMF.
A CeeNU, CCNU, Lomustine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CeeNU, CCNU, Lomustine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CeeNU, CCNU, Lomustine suppliers with CEP (COS) on PharmaCompass.